William P Forbes

William P Forbes

UNVERIFIED PROFILE

Are you William P Forbes?   Register this Author

Register author
William P Forbes

William P Forbes

Publications by authors named "William P Forbes"

Are you William P Forbes?   Register this Author

27Publications

528Reads

38Profile Views

Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.

Reg Anesth Pain Med 2016 Jan-Feb;41(1):93-8

From the *Thomas Jefferson University, Philadelphia, PA; and †Salix, a Division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AAP.0000000000000341DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684250PMC
September 2016

Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors.

Postgrad Med 2016 1;128(3):273-81. Epub 2016 Mar 1.

g Department of Medicine , University of Pennsylvania School of Medicine , Philadelphia , Pennsylvania , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00325481.2016.1152876DOI Listing
August 2016

Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.

J Clin Gastroenterol 2016 Apr;50(4):318-25

*Center for Digestive and Liver Diseases Inc., Mexico, MO†Connecticut Gastroenterology Institute, Bristol, CT‡Syracuse VA Medical Center, Syracuse, NY§Gastroenterology Associates of Central Georgia LLC, Macon, GA∥Nashville Medical Research Institute and The Maria Nathanson Center at Saint Thomas Hospital, Nashville, TN¶Salix, a Division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ#Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=01241398-900000000-9939
Publisher Site
http://dx.doi.org/10.1097/MCG.0000000000000414DOI Listing
April 2016

Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy.

Clin Gastroenterol Hepatol 2014 Aug 21;12(8):1390-7.e2. Epub 2013 Dec 21.

Salix Pharmaceuticals, Inc, Raleigh, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2013.12.021DOI Listing
August 2014

Long-term safety and tolerability of once-daily mesalamine granules in the maintenance of remission of ulcerative colitis.

Inflamm Bowel Dis 2014 Aug;20(8):1399-406

*Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and †Salix Pharmaceuticals Inc., Raleigh, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000076DOI Listing
August 2014

Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females.

Ann Pharmacother 2007 Feb 6;41(2):222-8. Epub 2007 Feb 6.

Clinical Research and Development, ICON Development Solutions, Ellicott City, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1H395DOI Listing
February 2007